Skip to main content
. Author manuscript; available in PMC: 2021 Jul 28.
Published in final edited form as: Hepatology. 2020 Oct;72(4):1242–1252. doi: 10.1002/hep.31157

TABLE 2.

Incidence of Cirrhosis and HCC

Cirrhosis HCC
Patients (n) Incident Cases (n) Follow-up (PY) Cirrhosis Incidences per 1,000 PY (95% CI) Incident Cases (n) Follow-up (PY) HCC Incidences per 1,000 PY (95% CI)
Steatosis + normal ALT 3,522 31 25,336 1.22 (0.83, 1.74) 5 25,441 0.20 (0.06, 0.46)
Steatosis + elevated ALT 15,419 435 112,950 3.85 (3.50, 4.23) 42 114,749 0.37 (0.26, 0.49)
No steatosis + normal ALT 9,267 61 62,955 0.97 (0.74, 1.24) 4 63,232 0.06 (0.02, 0.16)